Adverse Pathology after Radical Prostatectomy of Patients Eligible for Active Surveillance-A Summary 7 Years after Introducing mpMRI-Guided Biopsy in a Real-World Setting.

Benedikt EbnerMaria ApfelbeckNikolaos PyrgidisTobias NellessenStephan LedderosePaulo Leonardo PfitzingerYannic VolzElena BergBenazir EnzingerSeverin RodlerMichael AtzlerTroya IvanovaDirk-Andre ClevertChristian Georg StiefMichael Chaloupka

Published in: Bioengineering (Basel, Switzerland) (2023)

In this study, we show, in a real-world setting, that introducing FBx did not lead to significant change in ratio of adverse pathology for low-risk PCa patients after RP compared to SBx.

Keyphrases

end stage renal disease
radical prostatectomy
prostate cancer
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported outcomes
patient reported